Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis.

Enric ReverterJuan J LozanoCristina AlonsoAnnalisa BerzigottiSusana SeijoFanny TuronAnna BaigesMari L Martínez-ChantarJosé M MatoIbon Martínez-ArranzVincenzo la MuraVirginia Hernández-GeaJaume BoschJoan Carles García-Pagán

Published in: Liver international : official journal of the International Association for the Study of the Liver (2019)

The combination of two metabolites helps at identifying HVPG responders to acute propranolol. It could be a useful non-invasive test to classify the HVPG response to propranolol.

Keyphrases

liver failure
respiratory failure
drug induced
aortic dissection
mass spectrometry
ms ms
hepatitis b virus
extracorporeal membrane oxygenation
intensive care unit
acute respiratory distress syndrome
mechanical ventilation